Latest Breaking News On - Region languedoc roussillon - Page 1 : comparemela.com

An important milestone has been reached for the GNA NOW Consortium with the completion of the GLP toxicology studies for the NOSO-502 program. The results allow for the further development of the program to Phase 1 Utrecht, the Netherlands, and Lyon, France, 8 June 2022 – Nosopharm, a biotechnology company specializ.

Nordrhein westfalenFrance generalPoitou charentesZuid hollandFraunhofer institute for molecular biologyUniversity of poitiersErasmus mc university medical center rotterdamTechnology research instituteEuropean federation of pharmaceutical industriesInnovative medicines initiativeUniversity of liverpoolResearch unitEuropean consortiumUniversity campus of poitiers franceFrench ministry of defenseEuropean union